SPONSOR
McGill University Health Centre/Research Institute of the McGill University Health Centre
Total Trials
9
Recruiting
9
Phases
Phase 2, Phase 2, Phase 3
Conditions studied: Liver DysfunctionLiver Metastasis Colon CancerLiver RegenerationESRD, CKD Stage 4, CKD Stage 5Hypoxic-Ischemic EncephalopathyCongenital Heart DiseaseStroke HemorrhagicAneurysm CerebralCardiovascular DiseasesAortic Valve Stenosis
McGill University Health Centre/Research Institute of the McGill University Health Centre is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Liver Dysfunction, Liver Metastasis Colon Cancer, Liver Regeneration, ESRD, CKD Stage 4, CKD Stage 5.
The trial portfolio spans Phase 2, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — McGill University Health Centre/Research Institute of the McGill University Health Centre
How many clinical trials has McGill University Health Centre/Research Institute of the McGill University Health Centre sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre, of which 9 are actively recruiting participants. These trials cover conditions including Liver Dysfunction, Liver Metastasis Colon Cancer, Liver Regeneration. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does McGill University Health Centre/Research Institute of the McGill University Health Centre research focus on?
McGill University Health Centre/Research Institute of the McGill University Health Centre clinical trials span Liver Dysfunction, Liver Metastasis Colon Cancer, Liver Regeneration, ESRD, CKD Stage 4, CKD Stage 5, Hypoxic-Ischemic Encephalopathy, and additional conditions. The research pipeline includes Phase 2, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a McGill University Health Centre/Research Institute of the McGill University Health Centre clinical trial?
To participate in a McGill University Health Centre/Research Institute of the McGill University Health Centre trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all McGill University Health Centre/Research Institute of the McGill University Health Centre trials with current recruitment status updated daily.
Clinical Trials by McGill University Health Centre/Research Institute of the McGill University Health Centre
NCT06126419
Recruiting
Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration
Liver Dysfunction
NCT06182839 Phase 2
Recruiting
Canagliflozin in Advanced Renal Disease With MRI Endpoints
ESRD, CKD Stage 4, CKD Stage 5
NCT07732244
Recruiting
Evaluating a Wireless NIRS Device in the Neonatal Intensive Care Unit
Hypoxic-Ischemic Encephalopathy
NCT05930899
Recruiting
Translational-Omics in Aortic Stenosis (TOmAS) Biobank
Cardiovascular Diseases
NCT07739784
Recruiting
This Study Examines Whether Personality Traits Influence the Frequency or Severity of Ocular Adverse Effects Reported by Patients Using Glaucoma Medications. The Findings May Identify Patients at Greater Risk of Intolerance and Support More Personalized Treatment and Counselling.
Glaucoma
NCT06802003
Recruiting
Predicting Acute Exacerbations of COPD Using Wearable Devices and Remote Monitoring Technology With AI/ML Models
COPD
NCT07284511 Phase 2, Phase 3
Recruiting
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
Type 1 Diabetes
NCT06190626
Recruiting
Longitudinal Prospective Natural History Study of Retinopathy in Zellweger Spectrum Disorder
Zellweger Spectrum Disorder
NCT04249154 Phase 2
Recruiting
Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer
Prostate Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology